Pemphigus vulgaris: The manifestations and long-term management of 55 patients with oral lesions

British Journal of Dermatology

Volumn 140, Issue 1, 1999, Pages 84-89

  Scully, C ^a   Paes De Almeida, O ^a,b   Porter, S R ^a   Gilkes, J J H ^a,c  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c NONE   (United Kingdom)

Author keywords

Clinical features; Diagnosis; Management; Oral lesions; Pemphigus vulgaris

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CHEEK MUCOSA; CORTICOSTEROID THERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; ORAL DRUG ADMINISTRATION; PALATE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SIDE EFFECT; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONG-TERM CARE; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; PEMPHIGUS; TREATMENT OUTCOME;

EID: 0033049110     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02612.x     Document Type: Article

References (42)

1. Weinberg MA, Insler MS, Campen RB. Mucocutaneous features of autoimmune blistering diseases. Oral Surg Oral Med Oral Pathol 1997; 84: 517-34.
2. Gorsky M, Raviv M, Raviv E. Pemphigus vulgaris in adolescence. A case presentation and review of the literature. Oral Surg Oral Med Oral Pathol 1994; 77: 620-2.
3. Ahmed AR, Moy R. Death in pemphigus. J Am Acad Dermatol 1982; 7: 22-8.
4. Nishikawa T, Hashimoto T, Shimizu H et al. Pemphigus from immunofluorescence to molecular biology. J Dermatol Sci 1996; 12: 1-9.
5. Matzner Y, Erlich HA, Brautbar C et al. Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris. Acta Derm Venereol (Stockh) 1995; 75: 12-14.
6. Carcassi C, Cottoni F, Floris L et al. HLA haplotypes and class II molecular alleles in Sardinian and Italian patients with pemphigus vulgaris. Tissue Antigens 1996; 48: 662-7.
7. Degaldo JC, Yunis DE, Bozon MV et al. MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India. Tissue Antigens 1996; 48: 668-72.
8. Lombardi ML, Mercuro O, Tecame G et al. Molecular analysis of HLA DRB1 and DBQ1 in Italian patients with pemphigus vulgaris. Tissue Antigens 1996: 47: 228-30.
9. Laskaris G, Papovasiliou S, Bovopoulou O, Nicolis G. Association of oral pemphigus with chronic lymphocytic leukaemia. Oral Surg Oral Med Oral Pathol 1980; 2: 244-9.
10. Korman N, Eyre R, Zone J, Stanley J. Induced pemphigus: Autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol 1991; 96: 273-6.
11. Ruocco V, Brenner S, Lombardi ML. A case of diet-related pemphigus. Dermatology 1996; 192: 373-4.
12. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus: An update. Arch Dermatol 1996; 132: 203-12.
13. Mobini N, Padilla T, Ahmed AR. Long-term remission in selected patients with pemphigus vulgaris treated with cyclosporin. J Am Acad Dermatol 1997; 36: 264-6.
14. Ding X, Aoki V, Mascaro JM et al. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol 1997; 109: 592-6.
15. Korman N, Eyre RW, Klaus-Kovtun V, Stanley JR. Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliacens and pemphigus vulgaris. N Engl J Med 1989; 321: 631-5.
16. Mashkilleyson N, Mashkilleyson AL. Mucous membrane manifestations of pemphigus vulgaris. A 25-year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin. Acta Derm Venereol (Stockh) 1988; 68: 413-21.
17. Lamey PJ, Rees TD, Binnie WH et al. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Oral Surg Oral Med Oral Pathol 1992; 74: 54-7.
18. Laskaris G, Sklavounou A, Bovopoulou O. Juvenile pemphigus vulgaris. Oral Surg Oral Med Oral Pathol 1981; 51: 415-20.
19. Firth N, Rich A, Varigos G, Reade P. Oral pemphigus vulgaris in young adults. Int J Dermatol 1991; 30: 352-6.
20. Mahé A, Flageul B, Cissé I et al. Pemphigus in Mali: A study of 30 cases. Br J Dermatol 1996; 134: 114-19.
21. Zegarelli D, Zegarelli E. Intraoral pemphigus vulgaris. Oral Surg 1977; 44: 384-93.
22. Shklar G, Prim S, Flynn E. Gingival lesions of pemphigus. J Periodontol 1978; 49: 428-36.
23. Scully C, Porter SR. The clinical spectrum of desquamative gingivitis. In: Seminars in Cutaneous Medicine and Surgery (Arndt KA, LeBoit PE, Robinson JK et al. eds). Philadelphia: WB Saunders, 1997, 16, 308-13.
24. Porter SR, Kingsmill V, Scully C. Audit of diagnosis and investigation in patients with recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1993; 76: 449-52.
25. Shah R, Bilimoria KF. Oral pemphigus vulgaris. Clinico-pathological follow-up of 34 cases. J Oral Med 1983; 38: 170-3.
26. Laskaris G. Oral pemphigus vulgaris: An immunofluorescent study of fifty-eight cases. Oral Surg J Oral Med Oral Pathol 1981; 51: 626-31.
27. Handlers J, Melrose RJ, Abrams A, Taylor R. Immunoperoxidase technique in diagnosis of oral pemphigus vulgaris: An alternative method to immunofluorescence. Oral Surg Oral Med Oral Pathol 1982; 54: 207-12.
28. Sams WM, Jordon RE. Correlations of pemphigoid and pemphigus antibody litres with disease activity. Br J Dermatol 1971: 84: 7-13.
29. O'Loughlin S, Goldman G, Provost T. Fate of pemphigus antibody following successful therapy. Arch Dermatol 1978: 114: 1769-72.
30. Judd KP, Lever WF. Correlation of antibodies in skin and serum with disease severity in pemphigus. Arch Dermatol 1979; 115: 428-32.
31. Acosta E, Gilkes J, Ivanyi L. Relationship between the serum antibody titres and the clinical activity of pemphigus vulgaris. Oral Surg Oral Med Oral Pathol 1985; 60: 611-14.
32. Miyagawa S, Hojo H, Ishii J et al. Isolation and characterisation of soluble epidermal antigens reactive with pemphigus antibodies. Acta Derm Venereol (Stockh) 1977; 57: 7-13.
33. Diaz L, Patel H, Calvanico N. Isolation of pemphigus antigen from human saliva. J Immunol 1986; 2: 760-5.
34. Mourellou O, Chaidemenos GC, Koussidou T, Kapetis E. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period. Br J Dermatol 1995; 113: 83-7.
35. Bystryn JC. Adjuvant therapy of pemphigus. Arch Dermatol 1984; 120: 941-51.
36. Kuffer R. Bullous diseases. In: Innovations and Developments in Noninvasive Orofacial Health Care (Porter, SR, Scully, C. eds). Northwood: Science Reviews, 1996; 109-26.
37. Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 1996; 34: 645-52.
38. Bewley AP, Keefe M. Successful treatment of pemphigus vulgaris by pulsed immunoglobulin therapy. Br J Dermatol 1996; 135: 128-9.
39. Werth VP. Treatment of pemphigus vulgaris with brief high-dose intravenous glucocorticoids. Arch Dermatol 1996; 132: 1435-9.
40. Pasricha JS, Khaitan BK, Raman RS, Chandra M. Dexamethasone-cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995; 34: 875-82.
41. Eisen D, Ellis CN. Topical cyclosporin for oral mucosal disorders. J Am Acad Dermatol 1990; 23: 1259-64.
42. Gooptu C, Staughton RCD. Use of topical cyclosporin in oral pemphigus. J Am Acad Dermatol 1998; 38: 860-1.